Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DR26FHZ6Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,563
Award facts
- Contract value 100% obligated
- $24,563.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,563.47 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pens on November 14, 2025, with completion scheduled for November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. As a non-set-aside awardee winning through open competition, AmerisourceBergen has established itself as a reliable supplier of both brand-name and generic pharmaceuticals to support military and veteran healthcare needs. This delivery order for Wegovy, a GLP-1 receptor agonist medication, reflects the company's continued role in supplying specialized pharmaceutical products through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FHZ6Y?
SPE2DR26FHZ6Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FHZ6Y worth?
The government has obligated $24,563 on SPE2DR26FHZ6Y.
Is contract SPE2DR26FHZ6Y an order under another contract?
Yes. SPE2DR26FHZ6Y is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHZ6Y competed?
The extent of competition for SPE2DR26FHZ6Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award